Which are needed administrations of stimulating drugs (excluding anticancer drugs)
Conditions
Interventions
Venipuncturing with unapproved peripheral intravenous catheter
Sponsors
Kurokawa Mineo
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1)Who are scheduled to administrate stimulating drugs* (excluding anticancer drugs) using PIVC. (*Cytotoxic agents, Vesicant solutions, Irritant solutions, Hyperosmotic agents) 2)Over 19 years, regardless of gender 3)Who can expect continuous infusion therapy over 24 hours 4)Who have obtained their own written consent
Exclusion criteria
Exclusion criteria: 1)Who are unable to maintain the position to fully rotate the shoulder joint and rotate the elbow joint 2)With skin disorders at the puncture site 3)With peripheral neuropathy 4)With a history of vasovagal reflex due to puncture 5)With a history of thrombosis 6)With end-stage renal disease (stage II or higher) 7)With abnormal blood coagulation or bleeding tendency (PT-INR 1.5 or more, APTT 36.1 seconds or more, while taking any anticoagulant or antiplatelet drug) 8)Who is planned of highly invasive tests (endoscopy, bronchoscopy) 9)Whose physician judges that participation in this study is inappropriate
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Unexpected device malfunctions and adverse events up to 7 days after placement of the new peripheral intravenous catheter, and Incidence of adverse events up to 24 hours after removal. | — |
Secondary
| Measure | Time frame |
|---|---|
| 1)Success rate of catheter placement 2)The incidence of Catheter failure 3)Subjective evaluation of catheter placement in patients | — |
Contacts
Public ContactRyoko Murayama
Gradiate School of Medicine, The University of Tokyo,
Outcome results
None listed